IMCC Competitors
| IMCC Stock | USD 1.15 0.02 1.77% |
Im Cannabis vs Flora Growth Correlation
Good diversification
The correlation between Im Cannabis Corp and FLGC is -0.03 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Im Cannabis Corp and FLGC in the same portfolio, assuming nothing else is changed.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Im Cannabis' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Im Cannabis Competition Correlation Matrix
Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Im Cannabis and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of IMCC and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Im Cannabis Corp does not affect the price movement of the other competitor.
High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between IMCC Stock performing well and Im Cannabis Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Im Cannabis' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| AKAN | 7.36 | (2.61) | 0.00 | (17.40) | 0.00 | 11.11 | 64.81 | |||
| RDHL | 3.68 | (0.26) | 0.00 | (0.05) | 0.00 | 7.77 | 46.87 | |||
| SHPH | 7.04 | (0.42) | 0.00 | 0.35 | 0.00 | 15.69 | 44.53 | |||
| MOVE | 10.99 | 3.14 | 0.41 | 1.32 | 6.69 | 16.73 | 164.71 | |||
| JAGX | 7.38 | (1.05) | 0.00 | (0.20) | 0.00 | 10.14 | 125.57 | |||
| NDRA | 5.13 | (0.28) | 0.00 | (0.19) | 0.00 | 12.24 | 38.62 | |||
| VERO | 15.59 | 4.41 | 0.30 | (3.87) | 11.06 | 10.24 | 516.97 | |||
| GRI | 7.91 | (3.50) | 0.00 | 8.20 | 0.00 | 11.88 | 77.14 | |||
| NAOV | 5.98 | (0.06) | 0.00 | 0.21 | 0.00 | 10.43 | 93.37 | |||
| FLGC | 5.71 | 0.14 | 0.00 | 0.04 | 0.00 | 9.42 | 30.99 |
Cross Equities Net Income Analysis
Compare Im Cannabis Corp and related stocks such as Akanda Corp, Redhill Biopharma, and Shuttle Pharmaceuticals Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AKAN | (1.9 M) | (1.9 M) | (1.9 M) | (1.9 M) | (1.9 M) | (1.9 M) | (1.9 M) | (1.9 M) | (1.9 M) | (1.9 M) | (2.3 M) | (8.1 M) | (11.7 M) | (32.3 M) | (4.1 M) | (3.7 M) | (3.9 M) |
| RDHL | (2.5 M) | (15.5 M) | (10.3 M) | (10.6 M) | (10.7 M) | (21.1 M) | (29.4 M) | (45.5 M) | (38.8 M) | (42.3 M) | (76.2 M) | (97.7 M) | (71.7 M) | 23.9 M | (8.3 M) | (7.4 M) | (7.8 M) |
| SHPH | (213.6 K) | (213.6 K) | (213.6 K) | (213.6 K) | (213.6 K) | (213.6 K) | (213.6 K) | (213.6 K) | (626.1 K) | (805.7 K) | (805.7 K) | (1.2 M) | (5 M) | (6.6 M) | (9.1 M) | (8.2 M) | (7.8 M) |
| MOVE | 545 K | 7.3 M | 5.6 M | 574 K | (3.5 M) | (3.5 M) | (3.5 M) | (3.5 M) | (3.5 M) | (8.4 M) | (14 M) | (22.6 M) | (30.2 M) | (29.3 M) | (23.7 M) | (21.4 M) | (20.3 M) |
| JAGX | (25.5 M) | (8.6 M) | (8.6 M) | (8.6 M) | (8.6 M) | (16.3 M) | (14.7 M) | (22 M) | (32.1 M) | (38.5 M) | (33.8 M) | (52.6 M) | (47.5 M) | (41.3 M) | (38.5 M) | (34.6 M) | (36.4 M) |
| NDRA | (2.2 M) | (2.2 M) | (2.2 M) | (2.2 M) | (2.2 M) | (2.3 M) | (2.8 M) | (5.4 M) | (9.8 M) | (13.3 M) | (11.7 M) | (11.2 M) | (13.2 M) | (10.1 M) | (11.5 M) | (10.4 M) | (10.9 M) |
| VERO | (23 M) | (23 M) | (23 M) | (23 M) | (23 M) | (23 M) | (21.8 M) | (17.8 M) | (28.7 M) | (42.3 M) | (82.8 M) | (22.1 M) | (43.7 M) | (37.2 M) | (47 M) | (42.3 M) | (44.4 M) |
Im Cannabis Corp and related stocks such as Akanda Corp, Redhill Biopharma, and Shuttle Pharmaceuticals Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Im Cannabis Corp financial statement analysis. It represents the amount of money remaining after all of Im Cannabis Corp operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Im Cannabis Competitive Analysis
The better you understand Im Cannabis competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Im Cannabis' competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Im Cannabis' competition over several years is one of the best ways to analyze its investment potential.| Better Than Average | Worse Than Peers | View Performance Chart |
Im Cannabis Competition Performance Charts
Five steps to successful analysis of Im Cannabis Competition
Im Cannabis' competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Im Cannabis Corp in relation to its competition. Im Cannabis' competition analysis typically involves several steps, including:- Identifying the key players in the market: This involves identifying the major competitors of Im Cannabis in the market, both direct and indirect, as well as new entrants and disruptive technologies.
- Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
- Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Im Cannabis' competitive landscape.
- Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Im Cannabis Corp, and developing a strategy to address them.
- Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Complement your Im Cannabis position
In addition to having Im Cannabis in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Preferred Stock ETFs Thematic Idea Now
Preferred Stock ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Preferred Stock ETFs theme has 19 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Preferred Stock ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Im Cannabis Correlation with its peers. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Will Biotechnology sector continue expanding? Could IMCC diversify its offerings? Factors like these will boost the valuation of Im Cannabis. Market participants price IMCC higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Im Cannabis data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (0.50) | Revenue Per Share | Quarterly Revenue Growth (0) | Return On Assets | Return On Equity |
Understanding Im Cannabis Corp requires distinguishing between market price and book value, where the latter reflects IMCC's accounting equity. The concept of intrinsic value - what Im Cannabis' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Im Cannabis' price substantially above or below its fundamental value.
Please note, there is a significant difference between Im Cannabis' value and its price as these two are different measures arrived at by different means. Investors typically determine if Im Cannabis is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Im Cannabis' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.